BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36173446)

  • 1. Inter-method agreement between wash-in and wash-out computed tomography for characterizing hyperattenuating adrenal lesions as adenomas or non-adenomas.
    Kim MJ; Kang KA; Kim CK; Park SY
    Eur Radiol; 2023 Mar; 33(3):2218-2226. PubMed ID: 36173446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperattenuating adrenal lesions in lung cancer: biphasic CT with unenhanced and 1-min enhanced images reliably predicts benign lesions.
    Lee HY; Oh YL; Park SY
    Eur Radiol; 2021 Aug; 31(8):5948-5958. PubMed ID: 33459853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.
    Koo HJ; Choi HJ; Kim HJ; Kim SO; Cho KS
    Eur Radiol; 2014 Jun; 24(6):1410-20. PubMed ID: 24647823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses.
    Schloetelburg W; Ebert I; Petritsch B; Weng AM; Dischinger U; Kircher S; Buck AK; Bley TA; Deutschbein T; Fassnacht M
    Eur J Endocrinol; 2021 Dec; 186(2):183-193. PubMed ID: 34813495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing adrenal adenomas from non-adenomas with multidetector CT: evaluation of percentage washout values at a short time delay triphasic enhanced CT.
    Liu T; Sun H; Zhang H; Duan J; Hu Y; Xie S
    Br J Radiol; 2019 Feb; 92(1094):20180429. PubMed ID: 30433826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing pheochromocytoma from adrenal adenoma by using modified computed tomography criteria.
    Kang S; Oh YL; Park SY
    Abdom Radiol (NY); 2021 Mar; 46(3):1082-1090. PubMed ID: 32951125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of adrenal lesions using MDCT wash-out parameters: diagnostic accuracy of several combinations of intermediate and delayed phases.
    Foti G; Malleo G; Faccioli N; Guerriero A; Furlani L; Carbognin G
    Radiol Med; 2018 Nov; 123(11):833-840. PubMed ID: 29923085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative Enhancement Ratio of Portal Venous Phase to Unenhanced CT in the Diagnosis of Lipid-poor Adrenal Adenomas.
    Nagayama Y; Inoue T; Kato Y; Tanoue S; Kidoh M; Oda S; Nakaura T; Hirai T
    Radiology; 2021 Nov; 301(2):360-368. PubMed ID: 34463552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Adrenal Hyperplasia From Adenoma by Use of CT Densitometry and Percentage Washout.
    Park SY; Park BK; Park JJ; Kim CK
    AJR Am J Roentgenol; 2016 Jan; 206(1):106-12. PubMed ID: 26700341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental adrenal lesions: Accuracy of quadriphasic contrast enhanced computed tomography in distinguishing adenomas from nonadenomas.
    Foti G; Faccioli N; Mantovani W; Malleo G; Manfredi R; Mucelli RP
    Eur J Radiol; 2012 Aug; 81(8):1742-50. PubMed ID: 21602008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoma characterization: adrenal protocol with dual-energy CT.
    Kim YK; Park BK; Kim CK; Park SY
    Radiology; 2013 Apr; 267(1):155-63. PubMed ID: 23329655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of relative wash-in ratio of adrenal lesions at early biphasic CT.
    Foti G; Faccioli N; Manfredi R; Mantovani W; Mucelli RP
    AJR Am J Roentgenol; 2010 Jun; 194(6):1484-91. PubMed ID: 20489087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of the 10 Hounsfield unit threshold for identifying adrenal adenomas: Can we improve?
    Kirsch MJ; Kohli MW; Long KL; Pitt SC; Schneider DF; Sippel RS; Dedhia PH
    Am J Surg; 2020 Oct; 220(4):920-924. PubMed ID: 32359690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
    Park BK; Kim CK; Kim B; Lee JH
    Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unenhanced Dual-Layer Spectral-Detector CT for Characterizing Indeterminate Adrenal Lesions.
    Nagayama Y; Inoue T; Oda S; Tanoue S; Nakaura T; Morinaga J; Ikeda O; Hirai T
    Radiology; 2021 Nov; 301(2):369-378. PubMed ID: 34427466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of adrenal CT in the differentiation of adenoma and pheochromocytoma.
    Altinmakas E; Perrier ND; Grubbs EG; Lee JE; Prieto VG; Ng CS
    Acta Radiol; 2020 Aug; 61(8):1080-1086. PubMed ID: 31791129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol.
    Kamiyama T; Fukukura Y; Yoneyama T; Takumi K; Nakajo M
    Radiology; 2009 Feb; 250(2):474-81. PubMed ID: 19037020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of hepatic CT and chemical-shift MRI to discriminate lipid-poor adrenal adenomas from hepatocellular carcinoma metastases.
    Nagayama Y; Hayashi H; Taguchi N; Yoshida R; Harai R; Kidoh M; Oda S; Nakaura T; Hirai T
    Abdom Radiol (NY); 2024 Mar; ():. PubMed ID: 38456897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal Adenomas versus Metastases: Diagnostic Performance of Dual-Energy Spectral CT Virtual Noncontrast Imaging and Iodine Maps.
    Nagayama Y; Inoue T; Oda S; Tanoue S; Nakaura T; Ikeda O; Yamashita Y
    Radiology; 2020 Aug; 296(2):324-332. PubMed ID: 32452733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal masses: CT characterization with histogram analysis method.
    Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
    Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.